Trulieve Cannabis Corp. (TRLV) stock
TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3033% below fair value
$10.33−0.57 (-5.23%)
Close on Nov 16, 2026Market cap $1.99BP/E –Yield –
Trulieve Cannabis total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Trulieve Cannabis's total debt was $89.39M at Jun 30, 2026. For fiscal 2025 it was $90.84M, down 18.9% from the year before. The highest annual figure on record is $115.86M in fiscal 2023.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $90.84M | -18.9% |
| FY2024 | Dec 31, 2024 | $111.95M | -3.4% |
| FY2023 | Dec 31, 2023 | $115.86M | +22.9% |
| FY2022 | Dec 31, 2022 | $94.25M | +1359.8% |
| FY2021 | Dec 31, 2021 | $6.46M | +61.4% |
| FY2020 | Dec 31, 2020 | $4.00M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $89.39M | -17.6% |
| Q1 FY2026 | Mar 31, 2026 | $90.10M | -18.9% |
| Q4 FY2025 | Dec 31, 2025 | $90.84M | -18.9% |
| Q3 FY2025 | Sep 30, 2025 | $107.67M | -4.5% |
| Q2 FY2025 | Jun 30, 2025 | $108.52M | -4.4% |
| Q1 FY2025 | Mar 31, 2025 | $111.14M | -3.4% |
| Q4 FY2024 | Dec 31, 2024 | $111.95M | -3.4% |
| Q3 FY2024 | Sep 30, 2024 | $112.76M | +22.2% |
| Q2 FY2024 | Jun 30, 2024 | $113.51M | +22.1% |
| Q1 FY2024 | Mar 31, 2024 | $115.01M | +23.0% |
| Q4 FY2023 | Dec 31, 2023 | $115.86M | +22.9% |
| Q3 FY2023 | Sep 30, 2023 | $92.31M | +1062.3% |
| Q2 FY2023 | Jun 30, 2023 | $92.96M | +2606.2% |
| Q1 FY2023 | Mar 31, 2023 | $93.52M | +1648.1% |
| Q4 FY2022 | Dec 31, 2022 | $94.25M | +1359.8% |
| Q3 FY2022 | Sep 30, 2022 | $7.94M | +495.8% |
| Q2 FY2022 | Jun 30, 2022 | $3.44M | -14.1% |
| Q1 FY2022 | Mar 31, 2022 | $5.35M | +33.7% |
| Q4 FY2021 | Dec 31, 2021 | $6.46M | – |
| Q2 FY2021 | Jun 30, 2021 | $1.33M | – |
| Q1 FY2021 | Mar 31, 2021 | $4.00M | – |
| Q4 FY2020 | Dec 31, 2020 | $4.00M | – |
See a number that looks wrong?